Cargando…
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
The COVID-19 pandemic has killed over 400 000 people globally. Ecological evidence indicates that countries with national universal BCG vaccination programs for tuberculosis (TB) prevention have a much lower incidence of severe COVID-19 and mortality compared with those that do not have such program...
Autores principales: | Koti, Madhuri, Morales, Alvaro, Graham, Charles H, Siemens, David Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342862/ https://www.ncbi.nlm.nih.gov/pubmed/32636240 http://dx.doi.org/10.1136/jitc-2020-001119 |
Ejemplares similares
-
BCG vaccine: Worrying proposal for COVID-19
por: Sarinho, Emanuel, et al.
Publicado: (2021) -
Is BCG vaccination causally related to reduced COVID‐19 mortality?
por: Miyasaka, Masayuki
Publicado: (2020) -
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
por: Vidotto, Thiago, et al.
Publicado: (2019) -
Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2020) -
Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance
por: Ren, Runhan, et al.
Publicado: (2017)